China Health Group (FRA:VNL1) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is China Health Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. China Health Group's Free Cash Flow for the three months ended in Dec. 2023 was €0.00 Mil. China Health Group's Revenue for the three months ended in Dec. 2023 was €0.45 Mil. Therefore, China Health Group's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, China Health Group's current FCF Yield % is -5.37%.

The historical rank and industry rank for China Health Group's FCF Margin % or its related term are showing as below:

FRA:VNL1' s FCF Margin % Range Over the Past 10 Years
Min: -39.39 Med: -6.53 Max: 24.61
Current: -22.52

During the past 13 years, the highest FCF Margin % of China Health Group was 24.61%. The lowest was -39.39%. And the median was -6.53%.

FRA:VNL1's FCF Margin % is ranked worse than
58.37% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.54 vs FRA:VNL1: -22.52

China Health Group FCF Margin % Historical Data

The historical data trend for China Health Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Group FCF Margin % Chart

China Health Group Annual Data

Trend

Dec12

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-0.76

23.02

-12.29

-39.39

-22.78

China Health Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of China Health Group's FCF Margin %

For the Diagnostics & Research subindustry, China Health Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Health Group's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, China Health Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where China Health Group's FCF Margin % falls into.

China Health Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

China Health Group's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-0.627	/	2.752
	=	-22.78 %

China Health Group's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	0.453
	=	0.00 %

China Health Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of China Health Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

China Health Group (FRA:VNL1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » China Health Group Inc (FRA:VNL1) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

08225:Hong Kong

Address

Building 17, Jianwai SOHO, Chaoyang District, Beijing, CHN

Website

http://www.chgi.net

China Health Group Inc is an investment holding company engaged in providing medical care facilities in the People's republic of china. The company provides provision of post launch market research, medical and medical market services (PM services), Provision of contracted pharmaceutical development services (PD services), Provision of contracted clinical research services (CR Services), Drugs technologies, and Other medical services. The majority of the revenue for the company comes from the provision of PM services.

China Health Group (FRA:VNL1) Headlines

No Headlines